Provider
QP11-20 Pharmacy Benefit Exclusion for Budesonide-Formoterol Fumarate Dihydrate Aerosol
Program effective Date: Jan 22, 2020
Search Results
Displaying 1521 - 1530 of 3878 results
Provider
QP10-20 Pharmacy Benefit Exclusion for Xenleta TM, Asparlas TM, Ogivri TM and Tranexamic Acid/Sodium Chloride
Program effective Date: Jan 22, 2020
Provider
QP9-20 Pharmacy Benefit Exclusion Healthcare Administered Drugs
Program effective Date: Jan 22, 2020
Provider
QP15-20 Commercial Medical Drug Exclusion List Expanded to Include Avsola
Program effective Date: Jan 22, 2020
Provider
QP14-20 New Service Type Options for Inpatient Admission Notifications on Availity Portal
Program effective Date: Jan 22, 2020
Provider
QP13-20 Blue Cross Blue Shield National Coordination of Care SM Overview
Program effective Date: Jan 22, 2020
Provider
QP6-20 Separate Remits Will be Sent for Processed Legacy Platform Runout Claims
Program effective Date: Jan 08, 2020
Provider
QP7-20 Pharmacy Benefit Exclusion for Vyondys 53 (golodirsen)
Program effective Date: Jan 08, 2020
Provider
QP1-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Palforzia and Viaskin Peanut (Peanut Allery Oral Immunotherapy)
Program effective Date: Jan 08, 2020
Provider
QP4-20 Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Behavioral Health Fax Back Notification Update
Program effective Date: Jan 08, 2020